EMA and The Netherlands Biopharm Opportunities

The European┬áMedicines Agency (EMA) is relocating from London to Amsterdam. According to EMA, the Seat Agreement allows EMA to function independently in the Netherlands. Similar agreements apply to other EU agencies located in the Netherlands. On Friday, 13 April 2018, the Dutch Council of Ministers agreed to sign the document. Quantify research reported earlier thisContinue reading “EMA and The Netherlands Biopharm Opportunities”